1. Home
  2. RELI vs EYEN Comparison

RELI vs EYEN Comparison

Compare RELI & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • EYEN
  • Stock Information
  • Founded
  • RELI 2013
  • EYEN 2014
  • Country
  • RELI United States
  • EYEN United States
  • Employees
  • RELI N/A
  • EYEN N/A
  • Industry
  • RELI Specialty Insurers
  • EYEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RELI Finance
  • EYEN Health Care
  • Exchange
  • RELI Nasdaq
  • EYEN Nasdaq
  • Market Cap
  • RELI 3.5M
  • EYEN 2.9M
  • IPO Year
  • RELI N/A
  • EYEN 2018
  • Fundamental
  • Price
  • RELI $1.47
  • EYEN $4.88
  • Analyst Decision
  • RELI
  • EYEN Hold
  • Analyst Count
  • RELI 0
  • EYEN 4
  • Target Price
  • RELI N/A
  • EYEN $2.00
  • AVG Volume (30 Days)
  • RELI 41.1K
  • EYEN 7.1M
  • Earning Date
  • RELI 07-24-2025
  • EYEN 05-19-2025
  • Dividend Yield
  • RELI N/A
  • EYEN N/A
  • EPS Growth
  • RELI N/A
  • EYEN N/A
  • EPS
  • RELI N/A
  • EYEN N/A
  • Revenue
  • RELI $14,208,143.00
  • EYEN $67,063.00
  • Revenue This Year
  • RELI N/A
  • EYEN $7,680.45
  • Revenue Next Year
  • RELI N/A
  • EYEN $315.38
  • P/E Ratio
  • RELI N/A
  • EYEN N/A
  • Revenue Growth
  • RELI 2.40
  • EYEN 663.82
  • 52 Week Low
  • RELI $0.97
  • EYEN $0.85
  • 52 Week High
  • RELI $18.53
  • EYEN $124.80
  • Technical
  • Relative Strength Index (RSI)
  • RELI 68.56
  • EYEN 86.35
  • Support Level
  • RELI $1.29
  • EYEN $1.62
  • Resistance Level
  • RELI $1.56
  • EYEN $2.30
  • Average True Range (ATR)
  • RELI 0.09
  • EYEN 0.53
  • MACD
  • RELI 0.03
  • EYEN 0.27
  • Stochastic Oscillator
  • RELI 80.00
  • EYEN 79.17

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

Share on Social Networks: